Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 22Dermatologic 4Genitourinary 3Gastrointestinal 3Gynecologic 2Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Breast Neoplasms 54Triple Negative Breast Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 6Breast Neoplasms, Male 4Melanoma 3Inflammatory Breast Neoplasms 3Breast Carcinoma In Situ 3Brain Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Merkel Cell 2Carcinoma, Ductal, Breast 2Bone Neoplasms 2To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Meningeal Carcinomatosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Glioblastoma 1Fatigue 1Estrogen Receptor Positive 1Deception 1Cardiotoxicity 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 10Gemcitabine 8Cyclophosphamide 7Filgrastim 5Docetaxel 5Carboplatin 5Trastuzumab 4Surveys and Questionnaires 4Nivolumab 4Doxorubicin 4Cisplatin 4poly ICLC 3pazopanib 3atezolizumab 3aldesleukin 3Taxes 3Radiotherapy 3Paclitaxel 3Oncolytic Virotherapy 3Irinotecan 3Ipilimumab 3Injections 3Drug Therapy 3Cetuximab 3Capecitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3spartalizumab 2palbociclib 2liposomal doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Radiation × Breast × Clear all
NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
14 enrolled
BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡